INSMED INC Short-Term Debt
INSMED INC (INSM) had Short-Term Debt of $8.69 million as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2016-08-04
- 2016-06-30: Debt, Current $8.69M.
- 2016-03-31: Debt, Current $5.67M.
- 2015-12-31: Debt, Current $3.11M.
- 2015-09-30: Debt, Current $25.26M.
| Period end | Debt, Current |
|---|---|
| 2016-06-30 | $8.69M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $5.67M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $3.11M 10-K · filed 2016-02-25 |
| 2015-09-30 | $25.26M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $25.12M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $24.99M 10-Q · filed 2015-05-07 |
| 2014-09-30 | $5.18M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $3.28M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $5.19M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $3.28M 10-K · filed 2014-03-06 |
| 2013-09-30 | -$7.05M 10-Q · filed 2013-11-05 |
| 2013-06-30 | -$4.65M 10-Q · filed 2013-08-06 |
| 2013-03-31 | -$4.88M 10-Q · filed 2013-05-07 |
| 2012-12-31 | -$3.01M 10-K · filed 2013-03-18 |
| 2012-09-30 | $592.00K 10-Q · filed 2012-11-07 |
| 2011-12-31 | $0.00 10-Q · filed 2012-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |